Episodic ataxia type 2: genes and variants
Explore variant evidence for Episodic ataxia type 2 across 3 analyzed proteins (CACNA1A, KCNA1, SCN2A). Linked ClinVar records include 136 pathogenic or likely pathogenic variants, 1,064 variants of uncertain significance and 286 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Episodic ataxia type 2
CACNA1A: Voltage-dependent P/Q-type calcium channel subunit alpha-1A
Its P/Q-type calcium current is a major trigger for neurotransmitter release at central synapses and is especially important in cerebellar circuits. Pathogenic variants cause a spectrum including familial hemiplegic migraine, episodic ataxia, spinocerebellar ataxia type 6, epilepsy, and developmental disorders.
93 ClinVar pathogenic / likely pathogenic and 1,101 uncertain variants in CACNA1A have source records linked to Episodic ataxia type 2. Association strength is not clinical gene validity.
KCNA1: Potassium voltage-gated channel subfamily A member 1
Its potassium current limits neuronal excitability and shapes action-potential repolarization, especially in axons and presynaptic terminals. Pathogenic variants classically cause episodic ataxia type 1 and can also produce epilepsy, myokymia, and related neurologic phenotypes.
27 ClinVar pathogenic / likely pathogenic and 224 uncertain variants in KCNA1 have source records linked to Episodic ataxia type 2. Association strength is not clinical gene validity.
SCN2A: Sodium channel protein type 2 subunit alpha
The protein forms Nav1.2, a voltage-gated sodium channel that carries sodium current during neuronal action potentials. By shaping neuronal excitability and signal propagation, it supports brain circuits involved in development, learning, and seizure susceptibility.
16 ClinVar pathogenic / likely pathogenic and 25 uncertain variants in SCN2A have source records linked to Episodic ataxia type 2. Association strength is not clinical gene validity.
Where Episodic ataxia type 2 variants cluster
- CACNA1A S4 of repeat III (positions 1339–1357): 8 of 91 ClinVar pathogenic / likely pathogenic variants, 11.6× more than its size predicts (a length-based count, not a validated hotspot).
- CACNA1A IV (positions 1550–1813): 25 of 91 ClinVar pathogenic / likely pathogenic variants, 2.6× more than its size predicts (a length-based count, not a validated hotspot).
- CACNA1A I (positions 85–363): 22 of 91 ClinVar pathogenic / likely pathogenic variants, 2.2× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Episodic ataxia type 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| KCNA1 T226R | 226 | Segment S2 | Pathogenic / likely pathogenic (★★) |
| KCNA1 T226M | 226 | Segment S2 | Pathogenic / likely pathogenic (★★) |
| KCNA1 P405L | 405 | Segment S6 | Pathogenic / likely pathogenic (★★) |
| KCNA1 P405A | 405 | Segment S6 | Pathogenic / likely pathogenic (★★) |
| CACNA1A D302N | 302 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1348W | 1348 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1358W | 1358 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A V1392M | 1392 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1660H | 1660 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1660C | 1660 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1666W | 1666 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A I1708T | 1708 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A Y62H | 62 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CACNA1A Y62C | 62 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CACNA1A S218L | 218 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A I711M | 711 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1348Q | 1348 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A V1392A | 1392 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1666P | 1666 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1666Q | 1666 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A I1809L | 1809 | IV | Pathogenic / likely pathogenic (★★) |
| KCNA1 I262T | 262 | Segment S3 | Pathogenic / likely pathogenic (★★) |
| KCNA1 I314T | 314 | S4-S5 linker | Pathogenic / likely pathogenic (★★) |
| KCNA1 V404I | 404 | Segment S6 | Pathogenic / likely pathogenic (★★) |
| CACNA1A E147K | 147 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A G297R | 297 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A T500M | 500 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A E532K | 532 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A G539R | 539 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A A628T | 628 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1345Q | 1345 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1351Q | 1351 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A G1754R | 1754 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A S1798L | 1798 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A V1808I | 1808 | IV | Pathogenic / likely pathogenic (★★) |
| SCN2A R937H | 937 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A V215A | 215 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A D302H | 302 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A E667K | 667 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A I711V | 711 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A V713M | 713 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A P1352L | 1352 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A T1355N | 1355 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1663Q | 1663 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A S1798P | 1798 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A A1807S | 1807 | IV | Pathogenic / likely pathogenic (★★) |
| KCNA1 L305F | 305 | Segment S4 | Pathogenic / likely pathogenic (★★) |
| KCNA1 G396V | 396 | Segment S6 | Pathogenic / likely pathogenic (★★) |
| CACNA1A P202L | 202 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A V1455M | 1455 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A S1468L | 1468 | III | Pathogenic / likely pathogenic (★★) |
| KCNA1 V174F | 174 | Segment S1 | Pathogenic / likely pathogenic (★★) |
| CACNA1A E101K | 101 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A R192Q | 192 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A H253Y | 253 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A C272Y | 272 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A R279C | 279 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A G293R | 293 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A G676R | 676 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A E1263K | 1263 | III | Pathogenic / likely pathogenic (★★) |
Showing 60 of 136.
Uncertain variants prioritized for review in Episodic ataxia type 2
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| KCNA1 G376R | 376 | Intramembrane | Conflicting reports (★) | +7: G376S at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.963 |
| KCNA1 E325K | 325 | Segment S5 | Uncertain (★) | +7: 3 other pathogenic changes within 3 positions; E325D at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.938 |
| KCNA1 P403T | 403 | Segment S6 | Uncertain (★) | +7: 4 other pathogenic changes within 3 positions; P403S at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.891 |
| CACNA1A R1672H | 1672 | IV | Conflicting reports (★) | +6: R1672P at the same position is pathogenic; REVEL 0.954 |
| CACNA1A R1678C | 1678 | IV | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R1678S at the same position is pathogenic; REVEL 0.959 |
| CACNA1A R1739W | 1739 | IV | Conflicting reports (★) | +6: R1739P at the same position is pathogenic; REVEL 0.933 |
| CACNA1A V1392L | 1392 | III | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; V1392A at the same position is pathogenic; REVEL 0.823 |
| CACNA1A R192W | 192 | I | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R192Q at the same position is pathogenic; REVEL 0.897 |
| CACNA1A V1806I | 1806 | IV | Uncertain (★) | +6: 6 other pathogenic changes within 3 positions; V1806A at the same position is pathogenic; REVEL 0.855 |
| CACNA1A A1391S | 1391 | III | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; A1391V at the same position is pathogenic; REVEL 0.829 |
Which prediction tools work for Episodic ataxia type 2
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 98 out of 100
- AlphaMissense: 97 out of 100
- ESM1b (LLR): 97 out of 100
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 84 out of 100
- phyloP: 82 out of 100
- SpliceAI: 54 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 33 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Developmental and epileptic encephalopathy also has ClinVar records linked to CACNA1A variants; they fall partly in the same places as the Episodic ataxia type 2 variants (85 pathogenic / likely pathogenic).
- Spinocerebellar ataxia also has ClinVar records linked to CACNA1A variants; they fall partly in the same places as the Episodic ataxia type 2 variants (28 pathogenic / likely pathogenic).
- Familial hemiplegic migraine also has ClinVar records linked to CACNA1A variants; they fall partly in the same places as the Episodic ataxia type 2 variants (26 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Episodic ataxia type 2 variants (204 pathogenic / likely pathogenic).
- Seizures, benign familial also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Episodic ataxia type 2 variants (167 pathogenic / likely pathogenic).
- Complex neurodevelopmental disorder also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Episodic ataxia type 2 variants (22 pathogenic / likely pathogenic).
- Spasms also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Episodic ataxia type 2 variants (14 pathogenic / likely pathogenic).
- Benign familial infantile epilepsy also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Episodic ataxia type 2 variants (6 pathogenic / likely pathogenic).
Diseases related to Episodic ataxia type 2
- Developmental and epileptic encephalopathy, also linked to CACNA1A and SCN2A
- Epilepsy, also linked to CACNA1A and SCN2A
- Focal epilepsy, also linked to CACNA1A and SCN2A
- Seizures, benign familial, also linked to SCN2A
- Amyotrophic lateral sclerosis, also linked to SCN2A
- Familial hemiplegic migraine, also linked to CACNA1A
- Cardiac arrhythmia, also linked to SCN2A
- Complex neurodevelopmental disorder, also linked to SCN2A
- Spinocerebellar ataxia, also linked to CACNA1A
- Myasthenic syndrome, also linked to KCNA1
- Spasms, also linked to SCN2A
- Generalized epilepsy - paroxysmal dyskinesia, also linked to KCNA1
Frequently asked questions
Which genes have records linked to Episodic ataxia type 2?
This view contains 3 analyzed proteins: CACNA1A, KCNA1, SCN2A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 136 pathogenic or likely pathogenic variants, 1,064 variants of uncertain significance and 286 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 10 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,601 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center